Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Multistate Avandia Settlement (July 2013)

GlaxoSmithKline paid $184 million to settle claims by 8 states (Kentucky, Louisiana, Maryland, Mississippi, New Mexico, South Carolina, West Virginia, and Utah) that the company illegally promoted the Avandia diabetes drug. The settlement resolved claims that GSK misled consumers about Avandia’s cardiovascular risks. The settlement also resolved allegations brought by Louisiana involving other Glaxo prescription drugs, which Glaxo agreed to settle for $45 million (see GlaxoSmithKline instance, “Louisiana Off-Label Marketing Lawsuit”). The total settlement was for $229 million and the company did not admit to any wrongdoing or liability. See related GlaxoSmithKline instance, “Multistate Avandia Settlement (November 2012)”.

Misconduct Type
Health
Enforcement Agency
State/Local
Contracting Party
None
Court Type
Civil
Disposition
Settlement
Date of Settlement Announcement
7/24/2013
Contractors Involved Penalty
Total
GlaxoSmithKline $184,000,000
Further Information Released
GlaxoSmithKline Form 6-K (excerpt) 7/1/2013
Kentucky Complaint 2/20/2013

See also:

Federal Contractor Misconduct Database